Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0M7WS
|
|||
Drug Name |
Tricyclic compound 9
|
|||
Synonyms |
PMID27568917-Compound-Figure7(c)
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C15H11NO7
|
|||
Canonical SMILES |
CC1=CC(=C(C(=O)O1)C(=O)C=CC2=CC(=C(C=C2)O)[N+](=O)[O-])O
|
|||
InChI |
1S/C15H11NO7/c1-8-6-13(19)14(15(20)23-8)12(18)5-3-9-2-4-11(17)10(7-9)16(21)22/h2-7,17,19H,1H3/b5-3+
|
|||
InChIKey |
QYYBACCETRXSEX-HWKANZROSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Receptor-interacting protein 1 (RIPK1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Receptor-interacting protein 1 (RIPK1) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Necroptosis inhibitors as therapeutic targets in inflammation mediated disorders - a review of the current literature and patents.Expert Opin Ther Pat. 2016 Nov;26(11):1239-1256. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.